Positive expression of HIF-2alpha/EPAS1 in invasive bladder cancer

Urology. 2002 May;59(5):774-8. doi: 10.1016/s0090-4295(01)01607-7.

Abstract

Objectives: To investigate the expression of hypoxia-inducible factor (HIF)-2alpha/endothelial PAS domain protein 1 (EPAS1) in bladder cancer.

Methods: Two bladder cancer cell lines (T24, EJ-1) were examined for the expression of HIF-2alpha/EPAS1 mRNA by reverse transcriptase-polymerase chain reaction and HIF-2alpha/EPAS1 protein by Western blot analysis, respectively. Expression of HIF-2alpha/EPAS1 protein was also investigated immunohistochemically on paraffin-embedded sections from 24 patients with bladder cancer.

Results: HIF-2alpha/EPAS1 mRNA and protein could be detected in the two bladder cell lines under normoxia. The normal urothelium and all 7 superficial cases (pTis-pTa) were negative for HIF-2alpha/EPAS1. Five of the 8 pT1 cases (62.5%) and all 9 muscle-invasive cases were positive. The invasive compartment showed stronger HIF-2alpha/EPAS1 immunoreactivity compared with the superficial compartment. All the tumor clusters infiltrating to the interstitial tissue among muscle fibers showed moderate to strong positive staining.

Conclusions: HIF-2alpha/EPAS1 is mostly expressed in invasive bladder cancer, which indicates a possible role for HIF-2alpha/EPAS1 in the invasion of bladder cancer.

MeSH terms

  • Aged
  • Basic Helix-Loop-Helix Transcription Factors
  • Carcinoma, Transitional Cell / chemistry*
  • Female
  • Humans
  • Male
  • Neoplasm Proteins / analysis*
  • RNA, Messenger / analysis
  • Trans-Activators / analysis*
  • Tumor Cells, Cultured / chemistry
  • Urinary Bladder Neoplasms / chemistry*
  • Urinary Bladder Neoplasms / pathology

Substances

  • Basic Helix-Loop-Helix Transcription Factors
  • Neoplasm Proteins
  • RNA, Messenger
  • Trans-Activators
  • endothelial PAS domain-containing protein 1